In 2001, Dr. Rob Lambkin-Williams designed and implemented the first Human Viral Challenge Study to be conducted in Europe in the 21st century. He designed the first series of pilot studies, accommodating the regulatory challenges that this presented. He wrote the original protocols, ethics committee submissions, and oversaw the GMP quality standards for the virus used, the conduct of the studies in temporary quarantine facilities and the analysis of the data.